Bio-equivalency test standard to reinforce

Published: 2000-12-07 17:54:00

Updated: 2000-12-07 17:54:00

The KFDA plans to reinforce the bio-equivalency test standard to make its objectivity and to protect the testee's human rights. The standards will limit the number of overlapped testee's participation in the test and put additional clauses when violating test regulations.

Moreover, the standar...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK